The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics (how the drug effects certain target sites of activity in the body) of escalating doses of oral PF-04308515 in healthy volunteers for 14 days as well as one oral dose of a tablet formulation administered for 1 day.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01101932?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
